Scarica l'app Stockscreener
36.25
2.58%
-0.96
Dopo l'orario di chiusura:
35.92
-0.33
-0.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$37.21
Aprire:
$37.82
Volume 24 ore:
11.15M
Relative Volume:
0.44
Capitalizzazione di mercato:
$8.25B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
52.54
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
-7.34%
1M Prestazione:
-1.97%
6M Prestazione:
-34.66%
1 anno Prestazione:
+20.75%
Intervallo 1D:
$35.68
$38.03
Intervallo di 1 settimana:
$35.68
$40.74
Portata 52W:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
36.25 | 8.47B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Healthcare Stocks To Keep An Eye OnDecember 15th - MarketBeat
Hims & Hers Health, Inc. $HIMS Holdings Raised by Nomura Holdings Inc. - MarketBeat
Castleark Management LLC Invests $2.92 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Marex Group plc Invests $53.63 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Q3 Earnings and Regulatory Challenges - Quiver Quantitative
Biomarker Testing Experiences - Trend Hunter
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - sharewise.com
Hims & Hers Expands Weight-Management Program to the United Kingdom - Finviz
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? - MSN
Why Novo Nordisk Stock Topped the Market on Thursday - AOL.com
Hims & Hers targets UK’s weight loss market - eMarketer
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Hims & Hers Health's Options: A Look at What the Big Money is Thinking - Benzinga
Insider Sell Alert: Perez Garcia Andrea G Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health (NYSE:HIMS) Director Garcia Andrea Perez Sells 2,500 Shares of Stock - MarketBeat
Hims stock falls after lawmakers propose GLP-1 compounding restrictions By Investing.com - Investing.com Nigeria
Hims stock falls after lawmakers propose GLP-1 compounding restrictions - Investing.com
High Short-Interest Stocks to Buy Before Q1 2026 - Investing.com
Hims & Hers launches weight-loss business in UK - pharmaphorum
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? - Finviz
Hims & Hers Health (NYSE:HIMS) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Hims & Hers Expands Weight Loss Program to the U.K. - Yahoo Finance
Hims & Hers (HIMS) Expands Weight Loss Program to the UK - GuruFocus
HIMS Expands Weight Loss Program to the UK - GuruFocus
Hims & Hers brings weight loss program to the U.K. (HIMS:NYSE) - Seeking Alpha
Hims and Hers to offer weight-loss treatments in UK - The Mighty 790 KFGO
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK - PA Media
Hims & Hers launches weight loss program in UK with Hers platform - StreetInsider
Does The Rally In Hims And Hers Health Still Leave Room For Growth In 2025 - Yahoo Finance
(HIMS) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
What Analysts Think Is Changing the Hims and Hers Story for Long Term Investors - Yahoo Finance
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? - Finviz
Barclays Initiates Coverage on Hims & Hers Health (HIMS) with Ov - GuruFocus
5 High Short-Interest Stocks to Buy Before Q1 2026 - MarketBeat
XTX Topco Ltd Cuts Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Barclays Initiates Hims & Hers Health With Overweight Rating, $48 Price Target - marketscreener.com
Invesco Ltd. Purchases 2,128,587 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers' YourBio Health Acquisition: How They Are About To Revolutionize Blood Testing! - Smartkarma
Barclays Initiates Coverage of HIMS with Positive Outlook - GuruFocus
Andrew Dudum: 100 Most Influential People in Healthcare 2025 - Modern Healthcare
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Pharma company eyes Canada as patents lapse on weight-loss drugs - Benefits and Pensions Monitor
Truist Securities reiterates Hold rating on Hims and Hers stock amid soft Q4 trends - Investing.com UK
Divisadero Street Capital Management LP Sells 646,934 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Why Hims & Hers Stock Slipped Today - AOL.com
Promising Healthcare Stocks To Add to Your WatchlistDecember 7th - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Telehealth Trends - Quiver Quantitative
Jump Financial LLC Sells 155,479 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers: The Market's Panic Is Irrational (NYSE:HIMS) - Seeking Alpha
Arrowstreet Capital Limited Partnership Has $28.36 Million Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Stake Lowered by State Board of Administration of Florida Retirement System - MarketBeat
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):